FDA Inspection
Carie Boyd Pharmaceuticals LLCCarie Boyd Pharmaceuticals LLC – FDA Inspection, Nov 12, 2019
Record Details
This FDA Inspection record concerns Carie Boyd Pharmaceuticals LLC, with an inspection on November 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 12, 2019
- Product Type
- Drugs
View Company Profile
ID · 5952d58b-2fad-4681-8f34-e1c80067edfc
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1109663
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carie Boyd Pharmaceuticals LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| July 18, 2025 | Not classified | Dallas District Office | Drug Quality Assurance |
| June 21, 2024 | OAI | Drug Quality Assurance | |
| June 27, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 12, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Carie Boyd Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.